Health Condition 1: N709- Salpingitis and oophoritis, unspecified Health Condition 2: N72- Inflammatory disease of cervix uteri
Conditions
Interventions
Intervention1: Olanzapine: GROUP A will be given one tablet of 10mg oral olanzapine in the preoperative area, one hour before surgery and will be assessed for incidence of postoperative nausea and vo
Sponsors
Dr Prasanta Kumar Das
Eligibility
Inclusion criteria
Inclusion criteria: Gynecological patients undergoing laparoscopic surgeries ASA 1 and 2
Exclusion criteria
Exclusion criteria: no consent, allergic to study drugs, renal and hepatic failure, on antiemetic and antipsychotic medications, prolonged qt interval, history of obstructive sleep apnea
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the incidence of PONV in first 24 hours after surgery between two groupsTimepoint: To compare the incidence of PONV in first 24 hours after surgery between two groups | — |
Secondary
| Measure | Time frame |
|---|---|
| severity of nausea and vomting by 4- point severity scaleTimepoint: over 24 hours;requirement of rescue antiemetic (inj.Metoclopramide 10mg IV)Timepoint: 12 hours;Quality of recovery(QoR - 15)Timepoint: over 24 hours;Side effects of OlanzapineTimepoint: over 24 hours | — |
Countries
India
Contacts
Public ContactDr Nirmala Phobba
AIIMS BHUBANESWAR
Outcome results
None listed